FN2 Earnings Intelligence
Labcorp Holdings Inc. financials
Labcorp Holdings Inc. (LH) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,472.7 | $430 | $536.8 | $1,518.7 | $532.3 | - | - |
| + Debt | $5,418 | $5,340.1 | $5,054.5 | $6,331.5 | $5,084.9 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $16,120.9 | $14,876.8 | $12,161.6 | $13,008.9 | $13,951.7 | $14,705.2 | $15,405 |
| % Growth | 15.3% | -7.7% | -18.3% | 7.0% | 7.2% | 5.4% | 4.8% |
| Gross Profit | $5,624.3 | $4,385.1 | $3,364.9 | $3,624.4 | $4,012.5 | - | - |
| % Margin | 34.9% | 29.5% | 27.7% | 27.9% | 28.8% | - | - |
| EBITDA | $4,004.6 | $2,407.8 | $1,302.9 | $1,730.2 | $2,065.8 | - | - |
| % Margin | 24.8% | 16.2% | 10.7% | 13.3% | 14.8% | - | - |
| Net Income | $2,377.3 | $1,279.1 | $418 | $746 | $876.5 | - | - |
| % Margin | 14.7% | 8.6% | 3.4% | 5.7% | 6.3% | - | - |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 | $18.02 | $19.46 |
| % Growth | 53.6% | -42.7% | -65.9% | 85.3% | 18.3% | 72.3% | 8.0% |
| Operating Cash Flow | $3,109.6 | $1,955.9 | $1,327.7 | $1,585.8 | $1,640.5 | - | - |
| CapEx | $460.4 | $481.9 | $453.6 | $489.9 | $434.5 | - | - |
| Free Cash Flow | $2,649.2 | $1,474 | $874.1 | $1,095.9 | $1,206 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $16,120.9 | $14,876.8 | $12,161.6 | $13,008.9 | $13,951.7 | $14,705.2 | $15,405 |
| Gross Profit | $5,624.3 | $4,385.1 | $3,364.9 | $3,624.4 | $4,012.5 | - | - |
| EBITDA | $4,004.6 | $2,407.8 | $1,302.9 | $1,730.2 | $2,065.8 | - | - |
| Net Income | $2,377.3 | $1,279.1 | $418 | $746 | $876.5 | - | - |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 | $18.02 | $19.46 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,472.7 | $430 | $536.8 | $1,518.7 | $532.3 |
| Short-term Debt | $1.5 | $301.3 | $999.8 | $1,000.3 | $0.3 |
| Long-term Debt | $5,416.5 | $5,038.8 | $4,054.7 | $5,331.2 | $5,084.6 |
| Total Debt | $5,418 | $5,340.1 | $5,054.5 | $6,331.5 | $5,084.9 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3,109.6 | $1,955.9 | $1,327.7 | $1,585.8 | $1,640.5 |
| Capital Expenditure | $460.4 | $481.9 | $453.6 | $489.9 | $434.5 |
| Free Cash Flow | $2,649.2 | $1,474 | $874.1 | $1,095.9 | $1,206 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 15.3% | -7.7% | -18.3% | 7.0% | 7.2% |
| Gross Margin | 34.9% | 29.5% | 27.7% | 27.9% | 28.8% |
| EBITDA Margin | 24.8% | 16.2% | 10.7% | 13.3% | 14.8% |
| Net Margin | 14.7% | 8.6% | 3.4% | 5.7% | 6.3% |
| FCF Margin | 16.4% | 9.9% | 7.2% | 8.4% | 8.6% |
| Diluted EPS Growth | 53.6% | -42.7% | -65.9% | 85.3% | 18.3% |